Varex Imaging Co. (NASDAQ:VREX – Get Free Report) CEO Sunny Sanyal sold 8,749 shares of the firm’s stock in a transaction dated Wednesday, April 2nd. The shares were sold at an average price of $11.24, for a total transaction of $98,338.76. Following the transaction, the chief executive officer now owns 190,193 shares of the company’s stock, valued at approximately $2,137,769.32. This trade represents a 4.40 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website.
Varex Imaging Stock Down 9.8 %
Shares of NASDAQ VREX traded down $1.12 during mid-day trading on Thursday, reaching $10.31. 380,880 shares of the company traded hands, compared to its average volume of 539,219. The company’s fifty day moving average is $12.99 and its two-hundred day moving average is $13.45. The company has a debt-to-equity ratio of 1.02, a quick ratio of 2.50 and a current ratio of 4.36. Varex Imaging Co. has a fifty-two week low of $10.19 and a fifty-two week high of $18.30. The stock has a market cap of $424.77 million, a PE ratio of -8.81 and a beta of 0.65.
Varex Imaging (NASDAQ:VREX – Get Free Report) last announced its earnings results on Thursday, February 6th. The company reported $0.07 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.04 by $0.03. Varex Imaging had a positive return on equity of 4.00% and a negative net margin of 5.79%. On average, analysts expect that Varex Imaging Co. will post 0.53 earnings per share for the current year.
Institutional Inflows and Outflows
Wall Street Analyst Weigh In
VREX has been the subject of several research analyst reports. Oppenheimer reduced their price target on shares of Varex Imaging from $30.00 to $23.00 and set an “outperform” rating for the company in a research report on Friday, February 7th. B. Riley reissued a “buy” rating and issued a $22.00 target price (up from $21.00) on shares of Varex Imaging in a research report on Friday, February 7th. Finally, StockNews.com upgraded shares of Varex Imaging from a “hold” rating to a “buy” rating in a report on Friday, February 7th.
Read Our Latest Analysis on VREX
About Varex Imaging
Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. The company operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers.
See Also
- Five stocks we like better than Varex Imaging
- 3 Small Caps With Big Return Potential
- Shares of RH Down Nearly 40%: Where Investors Can Turn To Now
- How to Find Undervalued Stocks
- Tariffs, Spin-Out, and R2 Updates Are Positive Signs for Rivian
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- Cathie Wood Loads Up on Baidu—Is It the Right Time to Buy?
Receive News & Ratings for Varex Imaging Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varex Imaging and related companies with MarketBeat.com's FREE daily email newsletter.